AAPL

268.44

-0.46%↓

MSFT

496.74

-0.03%↓

TSM

286.75

-0.82%↓

ORCL

238.64

-2.14%↓

ASML.US

1,013.8

-1.09%↓

AAPL

268.44

-0.46%↓

MSFT

496.74

-0.03%↓

TSM

286.75

-0.82%↓

ORCL

238.64

-2.14%↓

ASML.US

1,013.8

-1.09%↓

AAPL

268.44

-0.46%↓

MSFT

496.74

-0.03%↓

TSM

286.75

-0.82%↓

ORCL

238.64

-2.14%↓

ASML.US

1,013.8

-1.09%↓

AAPL

268.44

-0.46%↓

MSFT

496.74

-0.03%↓

TSM

286.75

-0.82%↓

ORCL

238.64

-2.14%↓

ASML.US

1,013.8

-1.09%↓

AAPL

268.44

-0.46%↓

MSFT

496.74

-0.03%↓

TSM

286.75

-0.82%↓

ORCL

238.64

-2.14%↓

ASML.US

1,013.8

-1.09%↓

Search

LightPath Technologies Inc

Suletud

7.7 2.26

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

7.57

Max

7.76

Põhinäitajad

By Trading Economics

Sissetulek

-3.5M

-7.1M

Müük

3M

12M

Kasumimarginaal

-57.79

Töötajad

345

EBITDA

-4.8M

-6.7M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+10.25% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

11. nov 2025

Turustatistika

By TradingEconomics

Turukapital

60M

371M

Eelmine avamishind

5.44

Eelmine sulgemishind

7.7

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

LightPath Technologies Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

7. nov 2025, 21:06 UTC

Suurimad hinnamuutused turgudel

JBS Down After Trump Calls for Probe into Meat-Packing Companies

8. nov 2025, 18:10 UTC

Tulu

10 Defensive Stocks with Market-Beating Yields -- Barrons.com

8. nov 2025, 13:10 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- Update

8. nov 2025, 12:00 UTC

Tulu

Apple's iPhone Air Is a Marketing Win and a Sales Flop -- WSJ

8. nov 2025, 10:30 UTC

Tulu

Why Car Insurers Are Under Pressure to Cut Rates -- Heard on the Street -- WSJ

8. nov 2025, 03:50 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- 4th Update

8. nov 2025, 03:41 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Expected to Top $10 Billion -- WSJ

8. nov 2025, 03:07 UTC

Omandamised, ülevõtmised, äriostud

Pfizer and Metsera Reach Deal Worth Up to $10 Billion -- WSJ

7. nov 2025, 22:36 UTC

Tulu

McDonald's Stock Challenged By a Tougher Economy, Analyst Says. Plus, Marriott, Snowflake, and More. -- Barrons.com

7. nov 2025, 22:22 UTC

Tulu

The Score: GM, Tesla, Palantir, American Airlines and More Stocks That Defined the Week -- WSJ

7. nov 2025, 22:03 UTC

Tulu

Constellation Software 3Q Rev $2.95B >CSU.T

7. nov 2025, 22:03 UTC

Tulu

Constellation Software 3Q Net $210M >CSU.T

7. nov 2025, 22:03 UTC

Tulu

Constellation Software 3Q EPS $9.89 >CSU.T

7. nov 2025, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

7. nov 2025, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

7. nov 2025, 20:59 UTC

Tulu

Palantir's CEO Says His Earnings Were the Best Ever. They Weren't Even the Best of the Week. -- Barrons.com

7. nov 2025, 20:26 UTC

Market Talk

Natural U.S. Gas Futures Extend Rally to Three Weeks -- Market Talk

7. nov 2025, 20:22 UTC

Tulu

Free-Spending Big Tech Dominates Earnings. As for the Rest: Don't Miss. -- Barrons.com

7. nov 2025, 20:04 UTC

Market Talk

Oil Futures Close Choppy Week With Losses -- Market Talk

7. nov 2025, 19:34 UTC

Market Talk

Gold Posts Small Gain for Week -- Market Talk

7. nov 2025, 19:31 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Prices of Gas-Fired Power Plants Have Room to Grow -- Market Talk

7. nov 2025, 19:17 UTC

Tulu

These Stocks Are Moving the Most Today: Tesla, Expedia, Take-Two, Block, Affirm, Sunrun, Globus Medical, JFrog, and More -- Barrons.com

7. nov 2025, 19:09 UTC

Tulu

Wendy's Turnaround Won't Be Easy. Earnings, and the Stock, Tell the Story. -- Barrons.com

7. nov 2025, 19:08 UTC

Tulu

KKR Defied Private-Equity Fundraising Slump in the Third Quarter -- WSJ

7. nov 2025, 18:31 UTC

Market Talk

U.S. Oil RIg Count Unchanged at 414 -- Market Talk

7. nov 2025, 17:27 UTC

Market Talk

EPA Announces New Exemptions to Biofuel Blending Rules -- Market Talk

7. nov 2025, 17:20 UTC

Market Talk

Eli Lilly GLP-1 Deal with Trump Administration Provides Net Boost -- Market Talk

7. nov 2025, 17:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

7. nov 2025, 17:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7. nov 2025, 17:20 UTC

Market Talk

Health Care Roundup: Market Talk

Võrdlus sarnastega

Hinnamuutus

LightPath Technologies Inc Prognoos

Hinnasiht

By TipRanks

10.25% tõus

12 kuu keskmine prognoos

Keskmine 8.5 USD  10.25%

Kõrge 10 USD

Madal 7.5 USD

Põhineb 3 Wall Streeti analüütiku instrumendi LightPath Technologies Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

3

Osta

0

Hoia

0

Müü

Tehniline skoor

By Trading Central

2.34 / 2.41Toetus ja vastupanu

Lühikene perspektiiv

Weak Bullish Evidence

Keskpikk perspektiiv

Neutral Evidence

Pikk perspektiiv

Strong Bullish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest LightPath Technologies Inc

LightPath Technologies, Inc. designs, develops, manufactures, and distributes optical components and assemblies. It offers precision molded glass aspheric optics, molded and diamond-turned infrared aspheric lenses, and other optical components used to produce products that manipulate light; and infrared products, including catalog and custom infrared optics. The company's products are used in defense products, medical devices, laser aided industrial tools, automotive safety applications, barcode scanners, optical data storage, hybrid fiber coax datacom, telecommunications, machine vision and sensors, and other sectors. It sells its products directly to customers in Europe and Asia. LightPath Technologies, Inc. was founded in 1985 and is headquartered in Orlando, Florida.
help-icon Live chat